Skip to main content
eScholarship
Open Access Publications from the University of California

UCSF

UC San Francisco Electronic Theses and Dissertations bannerUCSF

Investigating the immune response to Mycobacterium tuberculosis complex (MTBC) variable antigens

Abstract

Mycobacterium tuberculosis is the leading cause of death globally due to a single infectious agent. Currently, no effective vaccine against pulmonary tuberculosis, the primary adult disease caused by Mtb infection, exists. A large body of evidence suggests that CD4 T cell responses to Mtb infection are required to prevent disease, and thus most current vaccine studies aim to induce protective CD4 T cell responses. Unlike viral pathogens or bacteria that produce a toxin, Mtb has an exceptionally large number of suitable CD4 T cell antigens and ideal targets for inclusion in a vaccine have not been exhaustively identified. Intriguingly, efforts to identify signs of antigenic variation within the Mycobacterium tuberculosis complex, revealed that T cell antigens are hyperconserved. This suggests that most dominant T cell epitopes are not inducing immune responses that exert a selective pressure on Mtb during infection and may not be suitable for a vaccine. Additional studies identified a rare subset of antigens that did exhibit sequence variation within predicted T cell epitopes. I hypothesized that T cell responses to these antigens may be more protective. Utilizing a DNA vaccine platform and aerosol infection of multiple strains of mice, I was able to demonstrate that a vaccination with these antigens induced a CD4 T cell response and altered pathology in two strains of mice, independent of bacterial burden. I further demonstrated significant changes to the immune cell subsets responding to infection and to the characteristic granulomatous lesion mediated by variable antigen vaccination. Additionally, I showed that vaccination with these antigens significantly changed the immune cell composition in the lungs during infection. Lastly, I established novel experimental methods that will aid in investigating the mechanisms underlying these unique impacts of CD4 T cell responses to variable Mtb antigens.